Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 25,000 shares at $14.84 ($370K) on 2007-09-24, disclosed to the SEC on 2007-09-26.
Scheduled sale ($370k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.52 | 300 | $4K | 1.2% |
| 2 | $14.55 | 400 | $6K | 1.6% |
| 3 | $14.56 | 400 | $6K | 1.6% |
| 4 | $14.57 | 300 | $4K | 1.2% |
| 5 | $14.59 | 200 | $3K | 0.8% |
| 6 | $14.60 | 500 |
| $7K |
| 2.0% |
| 7 | $14.62 | 300 | $4K | 1.2% |
| 8 | $14.63 | 1,100 | $16K | 4.4% |
| 9 | $14.75 | 300 | $4K | 1.2% |
| 10 | $14.77 | 1,000 | $15K | 4.0% |
| 11 | $14.78 | 1,200 | $18K | 4.8% |
| 12 | $14.79 | 1,700 | $25K | 6.8% |
| 13 | $14.80 | 4,100 | $61K | 16.4% |
| 14 | $14.81 | 4,100 | $61K | 16.4% |
| 15 | $14.82 | 3,498 | $52K | 14.0% |
| 16 | $14.83 | 1,871 | $28K | 7.5% |
| 17 | $14.84 | 1,931 | $29K | 7.8% |
| 18 | $14.85 | 200 | $3K | 0.8% |
| 19 | $14.86 | 300 | $4K | 1.2% |
| 20 | $14.89 | 300 | $4K | 1.2% |
| 21 | $14.91 | 100 | $1K | 0.4% |
| 22 | $14.92 | 300 | $4K | 1.2% |
| 23 | $14.94 | 300 | $4K | 1.2% |
| 24 | $14.97 | 300 | $4K | 1.2% |
| Total | $14.78 avg | 25,000 | $370K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |